COVID-19 therapeutics in resource-constrained settings: Where are we and what do we need?

COVID-19 Clinical Research Coalition

To date, the few medications with proven effectiveness in COVID-19 are appropriate primarily for the treatment of severely ill, hospitalized patients in well-resourced healthcare settings. WHO recommends the use of monoclonal antibody treatment for people with early-stage COVID-19, but these treatments too are expensive and complex to use in resource-constrained settings. No proven medications for uncomplicated COVID-19 are widely available in low- and middle-income countries.

So where are we today with new and emerging therapeutics that would be both effective and affordable in preventing the progression of mild or moderate COVID-19 and thereby prevent hospitalization? A couple of promising treatments have emerged recently, with early efforts underway to make these drugs more available than COVID-19 vaccines have been. What are the current research priorities, and do current efforts meet the needs?

The COVID-19 Clinical Research Coalition is hosting a webinar that will:
• Summarize the therapeutics development landscape for COVID-19
• Discuss the challenges in prioritizing drugs to be studied
• Assess the treatment needs in low- and middle-income countries
• Discuss the challenges of ensuring affordable access to new therapeutics, and what can be done now to ensure equitable access globally to proven medicines.

Watch the recording


Welcome and introduction – Prof. Patricia García, Cayetano Heredia University, Peru

Where are we now with COVID-19 therapeutics? A Latin American perspective – Dr Ludovic Reveiz, PAHO, USA

Where are we now with COVID-19 therapeutics? A South African perspective – Dr Jeremy Nel, University of the Witwatersrand, South Africa

Practical realities in COVID-19 treatment now. What is needed? – Dr Samba Sow, Centre for Vaccine Development, Mali

Impact of recent clinical trial results on current research priorities – Dr Nathalie Strub-Wourgaft, DNDi, Switzerland

If medicines work, how can we ensure people get them? – Ms Leena Menghaney, MSF Access Campaign, India

Roundtable and Q&A – moderated by Dr Podjanee Jittamala, Faculty of Tropical Medicine, Mahidol University, Thailand, and Prof. Nick White, Mahidol-Oxford Research Unit, Thailand


To register for this event please visit the following URL: →



27 January 2022 - 14:00 - 15:30 CEST
Organized by: COVID-19 Clinical Research Coalition

Event Category